1 – 39 of 39
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
L-type Amino Acid Transporter 1 as a Therapeutic Target in Pancreatic Cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Anoikis-related genes linked with patient outcome in pancreatic cancer
(
- Contribution to journal › Article
- 2023
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
(
- Contribution to journal › Article
- 2022
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
(
- Contribution to journal › Published meeting abstract
- 2020
-
Mark
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling
(
- Contribution to journal › Article
- 2019
-
Mark
Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue
(
- Contribution to journal › Article
-
Mark
The Emerging Role of Calcium-activated Chloride Channel Regulator 1 in Cancer
(
- Contribution to journal › Scientific review
-
Mark
Is immunotherapy the holy grail for pancreatic cancer?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The role of PEDF in pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
The hippo signaling pathway in pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosis
(
- Contribution to journal › Article
- 2018
-
Mark
Centrosomal Abnormalities in Pancreatic Cancer : Molecular Mechanisms and Clinical Implications
(
- Contribution to journal › Scientific review
-
Mark
Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
High-density and targeted glycoproteomic profiling of serum proteins in pancreatic cancer and intraductal papillary mucinous neoplasm
(
- Contribution to journal › Article
-
Mark
Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Targeting dendritic cells in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Scientific review
-
Mark
Pancreatic cancer : Disease dynamics, tumor biology and the role of the microenvironment
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Characterization of histone-related chemical modifications in formalin-fixed paraffin-embedded and fresh-frozen human pancreatic cancer xenografts using LC-MS/MS
(
- Contribution to journal › Article
-
Mark
Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Pancreatic cancer stroma : controversies and current insights
(
- Contribution to journal › Scientific review
-
Mark
Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Paradoxical role of hmgb1 in pancreatic cancer : Tumor suppressor or tumor promoter?
(
- Contribution to journal › Scientific review
-
Mark
Immune checkpoint therapy for pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
Pancreatic cancer : Yesterday, today and tomorrow
(
- Contribution to journal › Article
-
Mark
Comprehensive analysis of histone related modifications of formaldehyde fixed paraffin embedded and fresh frozen pancreatic tumor xenografts using LC-MS/MS
(
- Contribution to journal › Article
- 2015
-
Mark
Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer.
(
- Contribution to journal › Article
-
Mark
Protein deep sequencing applied to biobank samples from patients with pancreatic cancer.
(
- Contribution to journal › Article
-
Mark
Radioimmunotherapy-a potential novel tool for pancreatic cancer therapy?
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Analysis of MUC4 Expression in Human Pancreatic Cancer Xenografts in Immunodeficient Mice.
(
- Contribution to journal › Article
-
Mark
Apicidin Sensitizes Pancreatic Cancer Cells to Gemcitabine by Epigenetically Regulating MUC4 Expression.
(
- Contribution to journal › Article
-
Mark
Novel anti-adhesive barrier Biobarrier reduces growth of colon cancer cells.
(
- Contribution to journal › Article
-
Mark
In vivo toxicity and biodistribution of intraperitoneal and intravenous poly-L-lysine and poly-L-lysine/poly-L-glutamate in rats.
(
- Contribution to journal › Article
- 2013
-
Mark
Prevention of pleural adhesions by bioactive polypeptides - a pilot study.
(
- Contribution to journal › Article
-
Mark
Comparison of MUC4 expression in primary pancreatic cancer and paired lymph node metastases.
(
- Contribution to journal › Article
- 2012
-
Mark
Enrichment of Murine CD68(+)CCR2(+) and CD68(+)CD206(+) Lung Macrophages in Acute Pancreatitis-Associated Acute Lung Injury.
(
- Contribution to journal › Article
-
Mark
The influence on abdominal adhesions and inflammation in rabbits after exposure to differently charged polypeptides
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Effects of Polylysine and Polyglutamate on Inflammation and the Normal Process of Peritoneal Healing After Surgery
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Prevention of Adhesions by PL/PG after Adhesiolysis
(
- Contribution to specialist publication or newspaper › Specialist publication article